Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Cowealth Medical Holding Co's annualized net income for the quarter that ended in Dec. 2025 was NT$-643 Mil. Cowealth Medical Holding Co's average shareholder tangible equity for the quarter that ended in Dec. 2025 was NT$2,691 Mil. Therefore, Cowealth Medical Holding Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was -23.89%.
The historical rank and industry rank for Cowealth Medical Holding Co's Return-on-Tangible-Equity or its related term are showing as below:
ROCO:4745'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -9.22 Med: 5.23 Max: 16.45
Current: -9.22
During the past 13 years, Cowealth Medical Holding Co's highest Return-on-Tangible-Equity was 16.45%. The lowest was -9.22%. And the median was 5.23%.
ROCO:4745's Return-on-Tangible-Equity is ranked worse than 66.09% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.055
vs ROCO:4745: -9.22
Cowealth Medical Holding Co (ROCO:4745) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Cowealth Medical Holding Co Return-on-Tangible-Equity Related Terms
Cowealth Medical Holding Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical Holding Co Return-on-Tangible-Equity Chart
ROCO:4745 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Cowealth Medical Holding Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical Holding Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Cowealth Medical Holding Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -23.89% mean?
Cowealth Medical Holding Co (ROCO:4745) has a Return-on-Tangible-Equity of -23.89% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Cowealth Medical Holding Co and its competitors. According to the industry distribution chart, Cowealth Medical Holding Co ranks #501 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 66.1%.
Is Cowealth Medical Holding Co's Return-on-Tangible-Equity too high?
Cowealth Medical Holding Co's current Return-on-Tangible-Equity is -23.89%. Based on the distribution chart, Cowealth Medical Holding Co ranks #501 out of 758 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Cowealth Medical Holding Co has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cowealth Medical Holding Co ranks #501 out of 758 companies for Return-on-Tangible-Equity. This places Cowealth Medical Holding Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 4.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.06, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Cowealth Medical Holding Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical Holding Co's current Return-on-Tangible-Equity is -23.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.07, compared to a current price of NT$14.35 — trading 9.8% above its estimated fair value. The current Return-on-Tangible-Equity is -23.89%. Cowealth Medical Holding Co's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current Return-on-Tangible-Equity is -23.89% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued.
The current stock price of NT$14.35 is trading 9.8% above its estimated GF Value™ of NT$13.07.
GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.
Key valuation signals for ROCO:4745:
Return-on-Tangible-Equity: -23.89%
GF Value™: NT$13.07 vs. price of NT$14.35 (9.8% above fair value)
No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
49GF Score
Get the complete analysis for ROCO:4745
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4745 has been successfully added to your 
